Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance

Go back to Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance

SurModics (SRDX) PT Lowered to $70 at Needham & Company

November 10, 2021 12:10 PM EST

Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $70.00 (from $76.00) while maintaining a Buy rating.

The analyst commented, "SRDX's F4Q21 revenue and EPS beat consensus. Initial FY22 revenue and EPS guidance was well below consensus... More

SurModics (SRDX) Tops Q4 EPS by 15c

November 10, 2021 7:37 AM EST

SurModics (NASDAQ: SRDX) reported Q4 EPS of ($0.10), $0.15 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $24 million versus the consensus estimate of $23.06 million.

GUIDANCE:

SurModics sees FY2022 EPS of ($1.75)-($1.25), versus the consensus of $0.21. SurModics sees... More